Allosteric Inhibitors of Bcr-Abl: Towards Novel Myristate-Pocket Binders

E-ISSN： 1873-4316|14|5|477-487

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.14, Iss.5, 2013-06, pp. : 477-487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of BCR-ABL Inhibitors on Anti-Tumor Immunity

Current Medicinal Chemistry, Vol. 18, Iss. 34, 2011-12 ,pp. : 5174-5184

Bentham Science Publishers

Access to resources Recommend Favorite

BCR-ABL as a target for novel therapeutic interventions

By Kindler T Meyer RG Fischer T

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 85-101

Informa Healthcare

Access to resources Recommend Favorite

Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib?

By Doggrell Sheila A Christensen Anne-Marie

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 1, 2011-01 ,pp. : 157-163

Informa Healthcare

Access to resources Recommend Favorite

New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check

By O'Hare Thomas Eide Christopher A Deininger Michael W

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 6, 2008-06 ,pp. : 865-878

Informa Healthcare

Access to resources Recommend Favorite

BCR-ABL Inhibitors in Chronic Myeloid Leukemia: Process Chemistry and Biochemical Profile

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2943-2959

Bentham Science Publishers

Access to resources Recommend Favorite